Edition:
United Kingdom

Biofrontera AG (B8FGn.DE)

B8FGn.DE on Xetra

7.40EUR
4:36pm BST
Change (% chg)

€0.23 (+3.21%)
Prev Close
€7.17
Open
€7.09
Day's High
€7.40
Day's Low
€7.09
Volume
159,389
Avg. Vol
63,479
52-wk High
€8.07
52-wk Low
€4.78

Latest Key Developments (Source: Significant Developments)

Biofrontera Nominates Franca Ruhwedel To Supervisory Board As Hansjörg Plaggemars Successor
Tuesday, 4 Jun 2019 

June 4 (Reuters) - BIOFRONTERA AG ::NOMINATES NEW CANDIDATE FOR THE SUPERVISORY BOARD.SUPERVISORY BOARD PROPOSES THAT PROF. DR. FRANCA RUHWEDEL BE ELECTED TO SUPERVISORY BOARD AS SUCCESSOR TO HANSJÖRG PLAGGEMARS.  Full Article

Deutsche Balaton Sets Compensation Price To Shareholders Of Biofrontera At EUR 7.20/Shr
Friday, 31 May 2019 

May 31 (Reuters) - Deutsche Balaton Ag ::COMPENSATION FOR VOLUNTARY ACQUISITION OFFER TO SHAREHOLDERS OF BIOFRONTERA SET AT EUR 7.20PER SHARE.  Full Article

Biofrontera Q1 Net Loss At EUR 3.0 Mln
Wednesday, 29 May 2019 

May 29 (Reuters) - BIOFRONTERA AG ::REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS.TOTAL REVENUE INCREASED 46% TO EUR 6.8 MILLION IN Q1 2019 COMPARED TO EUR 4.7 MILLION IN Q1 2018;.Q1 NET LOSS WAS EUR 3.0 MILLION OR 6 CENTS PER SHARE IN Q1 2019 COMPARED TO EUR 3.2 MILLION OR 8 CENTS PER SHARE IN Q1 2018.CASH AND CASH EQUIVALENTS WERE EUR 21.8 MILLION AS OF MARCH 31, 2019.OUTLOOK 2019: EXPECTS ANNUAL SALES OF AROUND EUR 35-40 MILLION.OUTLOOK 2019: RESULT FROM OPERATING ACTIVITIES OF EUR -7 TO -9 MILLION.  Full Article

Maruho Says Decides To Increase Offer Price To EUR 7.20/Shr Of Biofrontera
Thursday, 23 May 2019 

May 23 (Reuters) - Maruho Deutschland GmbH::SAYS DECIDES TO INCREASE OFFER PRICE TO EUR 7.20 PER SHARE OF BIOFRONTERA AG <<>>.MARUHO WILL OFFER SHAREHOLDERS EUR 7.20 PER SHARE IN CASH (PREVIOUSLY: EUR 6.60).MARUHO SAYS NEW OFFER PRICE AT PREMIUM OF 27.21% ON XETRA CLOSING PRICE OF BIOFRONTERA SHARE ON APRIL 1, 2019.MARUHO SAYS OTHER PARAMETERS OF TRANSACTION REMAIN UNAFFECTED BY INCREASE OF OFFER PRICE.  Full Article

Deutsche Balaton Biotech AG Says It Intends To Change Composition Of Management Board And Supervisory Board Of Biofrontera AG
Wednesday, 22 May 2019 

May 22 (Reuters) - Biofrontera AG ::DEUTSCHE BALATON BIOTECH AG SAYS INTEND TO CHANGE COMPOSITION OF MANAGEMENT BOARD AND SUPERVISORY BOARD OF BIOFRONTERA AG - SEC FILING.DEUTSCHE BALATON BIOTECH AG - SUBMITTED A PROPOSAL TO DISMISS THOMAS SCHAFFER, CFO OF BIOFRONTERA AG.DEUTSCHE BALATON BIOTECH AG - SUBMITTED A PROPOSAL TO DISMISS HERMANN LÜBBERT AS THE CHAIRMAN OF THE MANAGEMENT BOARD.DEUTSCHE BALATON BIOTECH AG - SUBMITTED A PROPOSAL TO DISMISS ULRICH GRANZER AS THE CHAIRMAN OF THE SUPERVISORY BOARD OF BIOFRONTERA AG.DEUTSCHE BALATON BIOTECH AG - MADE PROPOSAL SUPPORTING ELECTION OF MARK SIPPEL AS REPLACEMENT MEMBER OF SUPERVISORY BOARD OF BIOFRONTERA.  Full Article

Biofrontera FY Net Loss Narrows To EUR 9.6 Million
Monday, 29 Apr 2019 

April 29 (Reuters) - Biofrontera AG ::FY TOTAL REVENUE INCREASED 76% TO EUR 21.1 MILLION COMPARED TO EUR 12.0 MILLION IN 2017;.FY PRODUCT REVENUE INCREASED 98% TO EUR 21.0 MILLION COMPARED TO EUR 10.6 MILLION IN 2017;.FY NET LOSS WAS EUR (9.6) MILLION OR (0.20) PER SHARE COMPARED TO EUR (15.2) MILLION OR (0.42) PER SHARE IN 2017;.EXPECTS 2019 REVENUE TO BE IN RANGE OF EUR 35 MILLION AND EUR 40 MILLION.2019 LOSS ON OPERATIONS IS EXPECTED TO BE BETWEEN EUR 7 AND EUR 9 MILLION..2019 LOSS BEFORE INCOME TAXES IS EXPECTED TO BE BETWEEN EUR 9 AND 11 MILLION.  Full Article

Maruho Deutschland GmbH Says Offer To Acquire About 9.68 Pct Of Share Capital Of Biofrontera
Monday, 1 Apr 2019 

April 2 (Reuters) - Maruho Deutschland GMBH: :MARUHO DEUTSCHLAND GMBH -ACQUISITION OFFER IN FORM OF PARTIAL OFFER TO SHAREHOLDERS OF BIOFRONTERA TO BUY UP TO 4.3 MILLION OF REGISTERED NO-PAR VALUE SHARES.MARUHO DEUTSCHLAND GMBH - OFFER TO ACQUIRE ABOUT 9.68 % OF SHARE CAPITAL OF BIOFRONTERA AG, FOR A CASH CONSIDERATION OF EUR 6.60 PER SHARE.  Full Article

Biofrontera: Hansjoerg Plaggemars Dismissed As Member Of Supervisory Board By Local Court
Wednesday, 27 Mar 2019 

March 27 (Reuters) - Biofrontera AG ::DGAP-NEWS: BIOFRONTERA AG: CHANGES IN THE COMPOSITION OF THE SUPERVISORY BOARD.COLOGNE LOCAL DISTRICT COURT (AMTSGERICHT) DISMISSED HANSJÖRG PLAGGEMARS AS A MEMBER OF SUPERVISORY BOARD OF BIOFRONTERA AG.DISMISSAL RESOLUTION IS EFFECTIVE IMMEDIATELY. HOWEVER, AN APPEAL CAN BE FILED WITHIN ONE MONTH..  Full Article

Biofrontera Reports Positive Phase III Results With Ameluz
Wednesday, 20 Mar 2019 

March 20 (Reuters) - BIOFRONTERA AG ::REPORTS POSITIVE PHASE III RESULTS WITH AMELUZ(R) FOR PHOTODYNAMIC THERAPY OF ACTINIC KERATOSES ON THE EXTREMITIES AND TRUNK/NECK.RESULTS WILL BE UTILIZED FOR FILING OF LABEL EXTENSION WITH EUROPEAN MEDICINES AGENCY AND US FOOD AND DRUG ADMINISTRATION.PLANS TO SUBMIT FILING OF LABEL EXTENSION IN Q3 OF 2019.  Full Article

Biofrontera And Maruho Conclude Cooperation Agreement Regarding Branded Generics And Plan Collaboration On Expansion Of Indications And Distribution Of Ameluz
Tuesday, 19 Mar 2019 

March 19 (Reuters) - BIOFRONTERA AG ::BIOFRONTERA AND MARUHO CONCLUDE COOPERATION AGREEMENT REGARDING BRANDED GENERICS AND PLAN COLLABORATION ON EXPANSION OF INDICATIONS AND DISTRIBUTION OF AMELUZ(R).NEW IP AND RESULTS OF NEW PROJECT PHASE, INCLUDING PROJECT DOCUMENTATION, SHALL BE SHARED EQUALLY BY PARTIES.NEW PROJECT PHASE WILL REQUIRE UP TO EUR 1.1 MILLION IN RESEARCH COSTS.COSTS TO BE BORNE EXCLUSIVELY BY MARUHO.MARUHO AND BIOFRONTERA ARE ALSO CURRENTLY NEGOTIATING COOPERATION ON RESEARCH AND DEVELOPMENT OF FURTHER INDICATIONS FOR AMELUZ^(R) FOR TREATMENT OF ACNE.  Full Article